 Securities Litigation Partner James Josh Wilson Encourages Investors Who Suffered Losses Exceeding 50,000 In FibroGen To Contact Him Directly To Discuss Their OptionsNew York, New York--Newsfile Corp. - June 8, 2021 - Faruqi Faruqi, LLP, a leading national securities law firm, is investigating potential claims against FibroGen, Inc. FibroGen or the Company NASDAQ:FGEN and reminds investors of the June 11, 2021 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. If you suffered losses exceeding 50,000 investing in FibroGen stock or options between November... 